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comments of these two individuals that we initiated such a 
trial approximately 2 years ago. 
The Columbus Vascular Surgery Society Taylor Patch 
Study is a randomized, prospective clinical trial that was 
designed to test the efficacy of the Taylor patch. The 
participating surgeons are all members of the Columbus 
Vascular Surgery Society or the Cleveland Vascular Soci- 
ety. The participating surgeons are not reimbursed for their 
participation i this study. They are volunteering their time 
and skills in a truly altruistic manner in the pursuit of 
scientific truth, and they hope that their efforts will advance 
the field of clinical surgery and will benefit future genera- 
tions of patients and physicians. 
The primary objective of the study is to compare the 
5-year primary patency rate of infrainguinal polytetrafluo- 
roethylene grafts when used with or without a Taylor patch 
for patients with grade 1 (or worse) chronic limb ischemia 
as defined by the SVS/ISCVS. 4 The study is designed to 
accomplish several other objectives as well. To accomplish 
these objectives, patients will be observed at 30 days and at 
3, 6, 12, 24, 36, 48, and 60 months. At each follow-up 
visit, the participating surgeon will record the graft patency 
as defined by the SVS/ISCVS committee for reporting 
standards. 4 In addition, the participating surgeon will 
record if any interval events have occurred and will record 
the grade of chronic arterial insufficiency a and the patient's 
ambulatory status. 
We estimate that we will need 75 patients at each level 
of the distal anastomosis (225 patients in total). The first 
patient was randomized on May 27, 1994, and to date we 
have enrolled more than 70 patients. Our follow-up data is 
92% complete, but because of the relatively few number of 
patients who have had even 12 months of follow-up, it is 
inappropriate atthis time to comment on our early results. 
However, Dr. Ligush and others should rest assured that 
we will continue our efforts to use a randomized, prospec- 
tive clinical trial to test the hypothesis that the Taylor patch 
improves patency rates, and we encourage others to do the 
same. 
j. Gordon Wright, M_D 
On behalf of the participating surgeons in the Columbus Vas- 
cular Surgery Society Taylor Patch Trial 
Division of Vascular Surgery 
Ohio State University 
410 West Tenth Avenue 
Columbus, OH 43210 
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24/41/68525 
Cardiac enzymes in the blood salvaged uring 
abdominal aortic surgery 
To the Editors: 
Elevations in the levels of the enzymes used to diagnose 
myocardial infarction, that is, creatine kinase (CK), its 
isoenzyme CKMB, and lactate dehydrogenase (LDH), are 
known to occur after surgery in the absence of myocardial 
injury. These elevations are caused by trauma during 
surgery to tissues uch as muscle and red blood cells and 
make the diagnosis of myocardial infarction in the imme- 
diate postoperative p riod difficult.1 Additional diagnostic 
criteria, such as CKMB/total CK ratio and LDH1/LDH2 
isoenzymes ratio have been described to differentiate an 
increase in enzyme levels of cardiac origin from that of 
noncardiac origin in the postoperative p riod.l-3 
Intraoperative blood salvage and reinfusion after pro- 
cessing (centrifugation/washing) is widely used during 
abdominal aortic surgery to minimize donor blood use. 
The release of enzymes in the surgical field from trauma- 
tized tissues and the hemolysis caused by suction suggest 
that the salvaged blood may contain large amounts of CK, 
CKMB, and LDH. The reinfusion of this blood, by further 
increasing CKMB or total CK, or by changing LDH 
isoenzyme pattern, may invalidate the criteria used to 
diagnose myocardial infarction in the postoperative p riod. 
The purpose of this study was to determine whether the 
blood salvaged uring abdominal aortic surgery contains 
CK, CKMB, and LDH in amounts large enough to 
complicate the diagnosis of postoperative myocardial 
infarction. 
The study (IRB-approved) was performed on blood 
salvaged uring 13 elective procedures (10 aneurysms, 3 
aortoiliac occlusive disease). The patients (10 men and 
three women; average age, 66 years; range, 46 to 78) had 
normal preoperative CK and LDH levels and no history of 
neuromuscular disorders known to be associated with 
abnormally increased CK or LDH contents in the skeletal 
muscle. Surgery was performed with a midline transab- 
dominal approach with medial visceral rotation. Before 
aortic crossclamping, systemic heparin was administered 
intravenously in a dose of 75 U/kg. The aorta was repaired 
with a straight graft in nine instances and a bifurcated one 
in four. The blood was suctioned from the operative field 
with a standard assembly consisting of a Yankauer suction 
tip, 3.5 m of tubing (internal diameter 6 mm), and a 
cardiotomy reservoir. The negative pressure applied to the 
suction was usually 150 mm Hg and was increased up to 
300 mm Hg during periods of brisk bleeding. Citrate 
(ACD solution A, USP) was added to the aspirated blood 
in approximately a 1:7 ratio to prevent clotting. The 
salvaged blood was processed with a Cell Saver Plus 3 
device (Haemonetics Inc., Braintree, Mass.), operated in 
the standard protocol as preset by the manufacturer. Only 
the first unit of processed blood obtained in each operation 
was included in the study. From each unit a blood sample 
was taken for the following measurements: hematocrit 
(Hct); CK and LDH activity (U/L), with a Hitachi 747 
analyzer and commercially available reagents (Boeringher 
Mannheim Corp., Indianapolis, Ind.); CKMB (~tg/L) with 
an automated immunoassay (Abbott Laboratories, Abbott 
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Park, Ill.); and LDH isoenzyme pattern by electrophoresis 
(the latter analysis was performed in five samples only). The 
upper reference limits for normal values in our laboratory 
are: CK, 250 U/L; LDH, 240 U/L; and CKMB, 5 ~tg/L. 
The volume of blood in the units was measured by 
weighing the units and subtracting the weight of the empty 
bag, assuming 1 ml of processed blood is 1 gin. The total 
amount of each enzyme in the processed units was 
calculated from the unit volume, Hct, and enzyme con- 
centration with the formula: total enzyme amount = 
enzyme concentration × volume × (1 - Hct). 
The mean ( + SD) volume of blood in the processed 
units was 200 -+ 20 ml, with an Hct level of 51 - 5%. 
Enzyme concentrations in the processed blood were CK, 
55 + 54 U/L; LDH, 300 -+ 65 U/L; CKMB, 0.5 -+ 0.07 
~g/L. The-total amounts of enzymes per processed unit 
were CK, 6+6 U; LDH, 32-_+ 8 U ;  CKMB, 
0.05 + 0.01 ~g. The LDH isoenzym e pattern was essen- 
tially normal. 
The results indicate that blood salvaged uring aortic 
surgery and washed before reinfusion contains very small 
amounts of cardiac enzymes. The reinfusion into a patient 
of even several units of this blood is very unlikely to cause 
changes in CK and LDH (iso)enzymes concentrations that 
would confound the diagnosis of postoperative myocardial 
infarction. 
Sergio Gregoretti, MD 
Department of Anesthesiology 
University of Alabama t Birmingham 
920 Jefferson Tower 
619 S. 19th St. 
Birmingham, AL 35233-6810 
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Regarding "Lower extremity lymphedema caused by 
acquired immune deficiency syndrome-related 
Kaposi's sarcoma" 
To the Editors: 
We read with interest he case report of Allen et al. 
(J VAsc Suv, G 1995;22:178-81) about lower extremity 
lymphedema in a patient with AIDS-related Kaposi's 
sarcoma. The authors acknowledge that it is not known 
whether the tumor is the cause of the lymphedema, or 
whether, as others have suggested based on immunohis- 
tochemical studies,l.2 Kaposi's arcoma rises from diseased 
lymphatic endothelium. Lymphoscintography in AIDS 
patients with Kaposi's arcoma is abnormal, and resembles 
studies of patients with primary and acquired forms of 
lymphatic dysplasia. 3 Although the authors believe the 
tumor caused lymphedema in their patient, we treated a 
patient whose presentation supports the hypothesis that 
lymphedema c n predispose to the development of Kapo- 
si's sarcoma. 
CASE REPORT 
An Italian-American man with no risk factors for HIV 
presented at 80 years of age. He had undergone left 
popliteal aneurysm repair 10 years earlier. Three repairs of 
a left inguinal hernia had been performed since. Two 
months before admission, a femoropopliteal bypass with 
prosthetic graft material was performed; this graft occluded 
within a few weeks. Edema of the left leg had developed 
since the original operation and had progressed over the 
years; and it became severe after the most recent procedure. 
It was clinically consistent with lymphedema, presumably 
secondary to surgical interruption of the lymphatics. 
The patient underwent femorotibial bypass for symp- 
toms of rest pain, and the graft has remained patent for 3 
years at the time of this report. The lymphedema has been 
treated with graded compression stockings with good 
results, but he has had two bouts of lymphangitis. Two 
years after the most recent bypass, purple maculopapular 
lesions developed inthe pretibial area, which biopsy proved 
to be Kaposi's sarcoma. The lesions regressed with 
radiation therapy, and the lymphedema remains well- 
controlled through 1 year of follow-up. 
At least one other report has been published of 
lymphedema followed by the development of Kaposi's 
sarcoma. 4 Given the infrequency oflymphedema and rarity 
of Kaposi's sarcoma, these cases lend support o the still- 
accumulating pathologic data pointing to a lymphatic 
origin of the tumor. 
Matthew J. Dougherty, ME) 
I@ith D. Calligaro, MD 
Dominic A. DeLaurentis, ME) 
Section of Vascular Surgery 
Pennsylvania Hospital 
700 Spruce St., Suite 101 
Philadelphia, PA 19106 
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